Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

209 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of 2 Immunosuppression Minimization Strategies in Kidney Transplantation: The ALLEGRO Trial.
van den Born JC, Meziyerh S, Vart P, Bakker SJL, Berger SP, Florquin S, de Fijter JW, Gomes-Neto AW, Idu MM, Pol RA, Roelen DL, van Sandwijk MS, de Vries DK, de Vries APJ, Bemelman FJ, Sanders JSF. van den Born JC, et al. Among authors: roelen dl. Transplantation. 2024 Feb 1;108(2):556-566. doi: 10.1097/TP.0000000000004776. Epub 2024 Jan 19. Transplantation. 2024. PMID: 37650722 Clinical Trial.
Selective unresponsiveness to beta cell autoantigens after induction immunosuppression in pancreas transplantation with anti-interleukin-2 receptor antibody versus anti-thymocyte globulin.
van de Linde P, Vd Boog PJ, Tysma OM, Elliott JF, Roelen DL, Claas FH, de Fijter JW, Roep BO. van de Linde P, et al. Among authors: roelen dl. Clin Exp Immunol. 2007 Jul;149(1):56-62. doi: 10.1111/j.1365-2249.2007.03400.x. Epub 2007 Apr 25. Clin Exp Immunol. 2007. PMID: 17459076 Free PMC article. Clinical Trial.
The functional polymorphism Ala258Ser in the innate receptor gene ficolin-2 in the donor predicts improved renal transplant outcome.
Eikmans M, de Canck I, van der Pol P, Baan CC, Haasnoot GW, Mallat MJ, Vergunst M, de Meester E, Roodnat JI, Anholts JD, van Thielen M, Doxiadis II, de Fijter JW, van der Linden PJ, van Beelen E, van Kooten C, Kal-van Gestel JA, Peeters AM, Weimar W, Roelen DL, Rossau R, Claas FH. Eikmans M, et al. Among authors: roelen dl. Transplantation. 2012 Sep 15;94(5):478-85. doi: 10.1097/TP.0b013e31825c5967. Transplantation. 2012. PMID: 22892990
Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study.
Reinders ME, de Fijter JW, Roelofs H, Bajema IM, de Vries DK, Schaapherder AF, Claas FH, van Miert PP, Roelen DL, van Kooten C, Fibbe WE, Rabelink TJ. Reinders ME, et al. Among authors: roelen dl. Stem Cells Transl Med. 2013 Feb;2(2):107-11. doi: 10.5966/sctm.2012-0114. Epub 2013 Jan 24. Stem Cells Transl Med. 2013. PMID: 23349326 Free PMC article. Clinical Trial.
Diagnosis of early pancreas graft failure via antibody-mediated rejection: single-center experience with 256 pancreas transplantations.
de Kort H, Mallat MJ, van Kooten C, de Heer E, Brand-Schaaf SH, van der Wal AM, Roufosse C, Roelen DL, Bruijn JA, Claas FH, de Fijter JW, Bajema IM. de Kort H, et al. Among authors: roelen dl. Am J Transplant. 2014 Apr;14(4):936-42. doi: 10.1111/ajt.12624. Epub 2014 Feb 12. Am J Transplant. 2014. PMID: 24712331 Free article. Clinical Trial.
The PROCARE consortium: toward an improved allocation strategy for kidney allografts.
Otten HG, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas M, Spierings E, Hack CE, van Reekum F, van Zuilen AD, Verhaar MC, Bots ML, Seelen MA, Sanders JS, Hepkema BG, Lambeck AJ, Bungener LB, Roozendaal C, Tilanus MG, Vanderlocht J, Voorter CE, Wieten L, van Duijnhoven E, Gelens M, Christiaans M, van Ittersum F, Nurmohamed A, Lardy NM, Swelsen WT, van Donselaar-van der Pant KA, van der Weerd NC, Ten Berge IJ, Bemelman FJ, Hoitsma AJ, de Fijter JW, Betjes MG, Roelen DL, Claas FH. Otten HG, et al. Among authors: roelen dl. Transpl Immunol. 2014 Oct;31(4):184-90. doi: 10.1016/j.trim.2014.09.008. Epub 2014 Oct 1. Transpl Immunol. 2014. PMID: 25258025
Glycemic Stability Through Islet-After-Kidney Transplantation Using an Alemtuzumab-Based Induction Regimen and Long-Term Triple-Maintenance Immunosuppression.
Nijhoff MF, Engelse MA, Dubbeld J, Braat AE, Ringers J, Roelen DL, van Erkel AR, Spijker HS, Bouwsma H, van der Boog PJ, de Fijter JW, Rabelink TJ, de Koning EJ. Nijhoff MF, et al. Among authors: roelen dl. Am J Transplant. 2016 Jan;16(1):246-53. doi: 10.1111/ajt.13425. Epub 2015 Aug 19. Am J Transplant. 2016. PMID: 26288226 Free article.
209 results